Authors:
AALTOSETALA K
PALOMAKI H
MIETTINEN H
VUORIO A
KUUSI T
RAININKO R
SALONEN O
KASTE M
KONTULA K
Citation: K. Aaltosetala et al., GENETIC RISK-FACTORS AND ISCHEMIC CEREBROVASCULAR-DISEASE - ROLE OF COMMON VARIATION OF THE GENES ENCODING APOLIPOPROTEINS AND ANGIOTENSIN-CONVERTING ENZYME, Annals of medicine, 30(2), 1998, pp. 224-233
Authors:
KEKOMAKI S
HAMALAINEN I
KASTE M
KAUPPINENMAKELIN R
MIETTINEN H
PALOMAKI H
KONTULA K
Citation: S. Kekomaki et al., PLATELET FIBRINOGEN RECEPTOR POLYMORPHISM HPA-1 IN ACUTE MYOCARDIAL-INFARCTION AND ACUTE ISCHEMIC STROKE, Thrombosis and haemostasis, 1997, pp. 1041-1041
Authors:
ASPLUND K
BERMAN P
BLOMSTRAND C
DENNIS M
ERILA T
GARRAWAY M
HAMRIN E
HANKEY G
ILMAVIRTA M
INDREDAVIK B
KALRA L
KASTE M
LANGHORNE P
RODGERS H
SIVENIUS J
SLATTERY J
STEVENS R
SVENSSON A
WARLOW C
WILLIAMS B
WOODDAUPHINEE S
DELEO D
DRUMMOND A
FOGELHOLM R
LINCOLN N
PALOMAKI H
STRAND T
WILHELMSEN L
COUNSELL C
FRASER H
Citation: K. Asplund et al., HOW DO STROKE UNITS IMPROVE PATIENT OUTCOMES - A COLLABORATIVE SYSTEMATIC REVIEW OF THE RANDOMIZED TRIALS, Stroke, 28(11), 1997, pp. 2139-2144
Authors:
KONTULA K
YLIKORKALA A
MIETTINEN H
VUORIO A
KAUPPINENMAKELIN RK
HAMALAINEN L
PALOMAKI H
KASTE M
Citation: K. Kontula et al., ARG506GLN FACTOR-V MUTATION (FACTOR-V LEIDEN) IN PATIENTS WITH ISCHEMIC CEREBROVASCULAR-DISEASE AND SURVIVORS OF MYOCARDIAL-INFARCTION, Thrombosis and haemostasis, 73(4), 1995, pp. 558-560
Authors:
KASTE M
FOGELHOLM R
ERILA T
PALOMAKI H
MURROS K
RISSANEN A
SARNA S
Citation: M. Kaste et al., A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF NIMODIPINE INACUTE ISCHEMIC HEMISPHERIC STROKE, Stroke, 25(7), 1994, pp. 1348-1353
Citation: H. Palomaki et M. Kaste, RISK-FACTORS FOR CERVICAL ATHEROSCLEROSIS IN PATIENTS WITH TRANSIENT ISCHEMIC ATTACK OR MINOR ISCHEMIC STROKE - RESPONSE, Stroke, 25(1), 1994, pp. 226-226
Citation: H. Palomaki et M. Kaste, REGULAR LIGHT-TO-MODERATE INTAKE OF ALCOHOL AND THE RISK OF ISCHEMIC STROKE - IS THERE A BENEFICIAL EFFECT, Stroke, 24(12), 1993, pp. 1828-1832